{"id":4039,"date":"2020-01-15T14:30:47","date_gmt":"2020-01-15T12:30:47","guid":{"rendered":"https:\/\/alzheimer.noemi.lu\/?p=4039"},"modified":"2024-06-28T13:55:47","modified_gmt":"2024-06-28T12:55:47","slug":"epad-passes-the-mark-of-2000-research-participants-for-its-longitudinal-cohort-study","status":"publish","type":"post","link":"https:\/\/ep-ad.org\/index.php\/2020\/01\/15\/epad-passes-the-mark-of-2000-research-participants-for-its-longitudinal-cohort-study\/","title":{"rendered":"EPAD passes the mark of 2,000 research participants for its Longitudinal Cohort Study"},"content":{"rendered":"<p>The members of the <a href=\"https:\/\/alzheimer.noemi.lu\/\" target=\"_blank\" rel=\"noopener noreferrer\">EPAD<\/a> initiative are glad to announce that its Longitudinal Cohort Study has recruited its 2,000<sup>th<\/sup> research participant in Sheffield (UK) this 15<sup>th<\/sup> January. Congratulations to the EPAD team in Sheffield (pictured).<\/p>\n<p><em>\u201cSince we joined the project last year, patients in our area have been enthusiastic about the opportunities offered to them by participating in the EPAD project.\u00a0As researchers and clinicians with many years of experience of research in Alzheimer\u2019s disease, we have also been very enthusiastic about the possibilities that this programme offers.\u00a0 Myself and my team have been extremely excited about the endless possibilities for hypothesis testing that such a large number of patients with longitudinal monitoring and deep phenotyping offer to gain insight into the preclinical and prodromal features of Alzheimer\u2019s disease\u201d, said Annalena Venneri (principal investigator of the EPAD project in Sheffield).<\/em><\/p>\n<p>The EPAD Longitudinal Cohort Study started the recruitment on May 2016 and is composed of individuals who do not have dementia and are already participating in different cohort studies and clinics across Europe. Their participation in the project involve standardised tests and follow-up over several years.<\/p>\n<p>Currently, EPAD has\u00a029 study sites up and running across 9 European countries (i.e. Belgium, France, Greece, Italy, Netherlands, Spain, Switzerland, Sweden and UK). We are pleased that Cliniques Universitaires Saint-Luc (Brussels, Belgium) became the latest addition to the EPAD family and recruited their first research participants.<\/p>\n<p>EPAD is a Europe-wide collaboration aiming to improve the understanding of the early stages of Alzheimer\u2019s disease. It combines knowledge and expertise from 39 organisations across multiple sectors from academia and industry, bringing together a wealth of experience to its activities and making it the largest ever public-private partnership in Alzheimer\u2019s disease research.<\/p>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" title=\"Interactive or visual content\" src=\"https:\/\/flo.uri.sh\/visualisation\/1304924\/embed#?secret=48BAviLpYd\" data-secret=\"48BAviLpYd\" frameborder=\"0\" scrolling=\"no\" height=\"575\" width=\"500\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The members of the EPAD initiative are glad to announce that its Longitudinal Cohort Study has recruited its 2,000th research participant in Sheffield (UK) this 15th January. Congratulations to the EPAD team in Sheffield (pictured). \u201cSince we joined the project last year, patients in our area have been enthusiastic about the opportunities offered to them [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4070,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-4039","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/4039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/comments?post=4039"}],"version-history":[{"count":1,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/4039\/revisions"}],"predecessor-version":[{"id":10395,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/posts\/4039\/revisions\/10395"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media\/4070"}],"wp:attachment":[{"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/media?parent=4039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/categories?post=4039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ep-ad.org\/index.php\/wp-json\/wp\/v2\/tags?post=4039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}